ライフサイエンスコーパス: miscarriage

1 ndin misoprostol can be used to treat missed miscarriage.

2 numab for a refractory CD and which ended in miscarriage.

3 at least 1 fibroid, and 10.8% experienced a miscarriage.

4 nts are associated with an increased risk of miscarriage.

5 and vivax malaria both increase the risk of miscarriage.

6 y, or before conception, to decrease risk of miscarriage.

7 rombophilic women with unexplained recurrent miscarriage.

8 elevated ferritin conferred stronger risk of miscarriage.

9 with an OR of 0.62 (95% CI: 0.41, 0.93) for miscarriage.

10 pherol was associated with decreased risk of miscarriage.

11 d with an increased risk of second-trimester miscarriage.

12 vival among women with unexplained recurrent miscarriage.

13 ng vitamin D as a modifiable risk factor for miscarriage.

14 ons, they are not recommended for preventing miscarriage.

15 ation was a modifiable risk factor for early miscarriage.

16 The point is illustrated here in the case of miscarriage.

17 cterize the relationship between smoking and miscarriage.

18 be warned that smoking increases the risk of miscarriage.

19 ongitudinally measured urinary hCG and early miscarriage.

20 cessful because of retarded fetal growth and miscarriage.

21 e, resulting in 10 ongoing pregnancies and 1 miscarriage.

22 placental function in karyotypically normal miscarriage.

23 nce in reducing transfer of embryos prone to miscarriage.

24 ation in the placenta and that this leads to miscarriage.

25 regnancy stages at risk of influenza-related miscarriage.

26 rring equine EPLs at a similar rate to human miscarriage.

27 vitamins in early pregnancy and the risk of miscarriage.

28 A total of 524 women had a miscarriage.

29 r pregnancy-related complications, including miscarriage.

30 elation between chemokine levels and risk of miscarriage.

31 ic ovarian syndrome are at increased risk of miscarriage.

32 okines are associated with increased risk of miscarriage.

33 isoprostol alone in the management of missed miscarriage.

34 asn't a significant independent predictor of miscarriage.

35 k of blood sampling, and maternal history of miscarriage.

36 firming a strong association between hCG and miscarriage.

37 en linked to higher risks of infertility and miscarriage.

38 for-gestational-age birth weight but not for miscarriage.

39 y, multiple pregnancy, ectopic pregnancy, or miscarriage.

40 ce the proportion of pregnancies that end in miscarriage.

41 hat pre-implantation ZIKV infection leads to miscarriage.

42 sychological burden associated with multiple miscarriages.

43 ant increase in the risk of second trimester miscarriages.

44 omen with a history of unexplained recurrent miscarriages.

45 phisms, in vitro fertilization failures, and miscarriages.

46 morigenesis, neuropsychiatric conditions and miscarriages.

47 omal rearrangement, or a history of multiple miscarriages.

48 inflammation in the deciduas and leading to miscarriages.

49 maternal infections account for 15% of early miscarriages.

50 e placenta, and an increase in the number of miscarriages.

51 nic hypertransaminasemia (29%) and recurrent miscarriages (12%).

52 ic attendees, 12.4% (7.9-17.7) in women with miscarriage, 12.4% (9.4-15.7) in symptomatic women, and

53 omen with VIUP (256 pg/mL; 168-442 pg/mL) or miscarriage (192 pg/mL; 133-476 pg/mL).

54 Incidence of miscarriage (2% in the standard care group vs 2% in the

55 without preterm delivery (269 [26.4%]), and miscarriage (262 [25.7%]).

56 heparin was associated with a higher rate of miscarriage (28.6% versus 9.2%; P<0.001) and late fetal

57 % CI 1.78-7.66]), pregnancy complications or miscarriages (3.54 [1.47-8.55]), unwanted pregnancy (2.9

58 hedema 11%), sensorineural hearing loss 76%, miscarriage 33%, and hypothyroidism 14%.

59 included 256 women (mean age 32 years, >/=3 miscarriages: 72%; mean gestational age 39 days of ameno

60 from five different ancestries for sporadic miscarriage, 750 cases of European ancestry for multiple

61 Six miscarriages (8%) occurred during the first trimester.

62 PFAS was associated with 64% higher odds for miscarriage (95% CI: 1.15, 2.34).

63 There were significantly more miscarriages (adjusted odds ratio=1.94, 95% CI=1.08-3.48

64 Miscarriage affects 20% of pregnancies and maternal infe

65 a livebirth (AHR 13.0 [95% CI 11.63-16.86]), miscarriage (AHR 6.07 [95% CI 4.83-7.62]), or terminatio

66 malaria, maternal and neonatal anaemia, and miscarriage, all of which increase the overall importanc

67 Four women experienced miscarriage, all of whom had received antenatal systemic

68 dversely affect fertility or first trimester miscarriage, although it is associated with a significan

69 There were 537 observed miscarriages among 4,070 women, 23% of whom self-identif

70 Twenty-three percent had experienced a prior miscarriage and 52% prior births.

71 ur were education and previous experience of miscarriage and antenatal care.

72 Maternal age-related miscarriage and birth defects are predominantly a conseq

73 treatment of cancer and prevention of human miscarriage and birth defects.

74 inst the bleeding challenges associated with miscarriage and childbirth.

75 humans, and is the leading genetic cause of miscarriage and congenital birth defects.

76 due to an association with increased risk of miscarriage and congenital defects.

77 Defective crossing over causes infertility, miscarriage and congenital disease.

78 (ORs) and 95% confidence intervals (CIs) for miscarriage and each PFAS as a continuous variable or in

79 leagues extend this correlation to recurrent miscarriage and fetal growth restriction, revealing the

80 e) that shares features with human recurrent miscarriage and fetal growth restriction, we identified

81 Spontaneous miscarriage and fetal malformation rates after recovery

82 (0.2%) had both a history of early recurrent miscarriage and LAC positivity.

83 imester malaria and artemisinin treatment on miscarriage and major congenital malformations.

84 AS mixtures were associated with the risk of miscarriage and particularly among parous women.

85 Among women who were pregnant, miscarriage and perinatal mortality was 2.7 times higher

86 ciated with several complications, including miscarriage and premature delivery.

87 ae and G. vaginalis are associated with late miscarriage and prematurity in high-risk pregnancies.

88 ions seem to be associated with infertility, miscarriage and prematurity.

89 ies are associated with an increased risk of miscarriage and preterm birth, even when thyroid functio

90 CI 0.08-1.02], p = 0.053), or in the risk of miscarriage and stillbirth combined (pregnancy loss) (aH

91 We examined whether miscarriage and stillbirth increase later risk of myocar

92 atios for each of the outcomes by history of miscarriage and stillbirth.

93 l-for-gestational-age birth, stillbirth, and miscarriage and subsequent CVD.

94 7 weeks), growth restriction, pre-eclampsia, miscarriage and/or stillbirth.

95 There were 8 first-trimester miscarriages and 1 ectopic pregnancy.

96 (RPL) is defined as two or more consecutive miscarriages and affects an estimated 1.5% of couples tr

97 Errors in meiosis result in miscarriages and are the leading cause of birth defects;

98 romosomes in meiosis is essential to prevent miscarriages and birth defects.

99 luenza infection, the effect of influenza on miscarriages and births remains unclear.

100 regation errors, a leading cause of frequent miscarriages and congenital defects.

101 Causes for miscarriages and congenital malformations can be genetic

102 creased lead exposure to higher incidence of miscarriages and fetal death, even at blood lead elevati

103 be a good treatment for women with recurrent miscarriages and IUGR.

104 mber of chromosomes, is the leading cause of miscarriages and mental retardation in humans and is a h

105 nt of severe pregnancy complications such as miscarriages and preterm delivery.

106 nd reduced risks of P(4)-resistant recurrent miscarriages and remission of endometriosis, these findi

107 Research into the preventability of miscarriages and stillbirths is hampered in the United S

108 bryonic growth, manifesting in preeclampsia, miscarriages and/or preterm birth.

109 known incidence of chromosomal aneuploidy in miscarriage, and it has been suggested that there is an

110 he leading genetic abnormality that leads to miscarriage, and it is caused by a failure of accurate c

111 pherol was associated with increased risk of miscarriage, and low gamma-tocopherol was associated wit

112 m birth, preeclampsia, gestational diabetes, miscarriage, and stillbirth).

113 ree unexposed cohorts: women with livebirth, miscarriage, and termination of their first pregnancies.

114 ace is independently associated with risk of miscarriage, and the higher risk for black women is conc

115 Thirty-one women had a miscarriage, and three fetuses had intrauterine death.

116 ages lead to elevated rates of infertility, miscarriage, and trisomic conceptions.

117 pean ancestry for multiple (>=3) consecutive miscarriage, and up to 359,469 female controls.

118 egnancy, chose to have medical management of miscarriage, and were willing and able to give informed

119 velopmental delays, congenital skin lesions, miscarriage, and/or stillbirth.

120 pregnancies: 188 (56%) livebirths, 74 (22%) miscarriages, and 74 (22%) elective pregnancy terminatio

121 rst birth, number of still births, number of miscarriages, and lack of breastfeeding were positively

122 information on all livebirths, stillbirths, miscarriages, and neonatal deaths.

123 evels were associated with increased risk of miscarriage as the collection-outcome interval increased

124 The increased risk of miscarriage associated with high MF was consistently obs

125 We observed a monotonic increase in odds for miscarriage associated with increasing PFOA and PFHpS le

126 There was no difference in the risk of miscarriage associated with the use of artemisinins anyt

127 ely impaired placental formation, leading to miscarriage at days 10-12 of pregnancy.

128 In conclusion, the risk of miscarriage at high altitude is lower in Andean women.

129 e YS reliably identified the occurrence of a miscarriage at least 7 days prior its occurrence.

130 losses were not divided into stillbirths and miscarriages because gestational age was not reliably re

131 ined recurrent miscarriage (>/=2 consecutive miscarriages before 15 weeks' gestation) and a negative

132 ia trachomatis (Ct) has been associated with miscarriage but the underlying mechanisms are unknown.

133 c ovary syndrome (PCOS) commonly suffer from miscarriage, but the underlying mechanism of PCOS-induce

134 c ovary syndrome (PCOS) commonly suffer from miscarriage, but the underlying mechanisms remain unknow

135 osure during pregnancy increased the risk of miscarriage by 11% (95% CI: 0.95, 1.31; n = 17 studies).

136 The risk of miscarriage by ancestry was assessed using multivariate

137 16 years and older, diagnosed with a missed miscarriage by pelvic ultrasound scan in the first 14 we

138 valuation of a historic construction-related miscarriage cluster in the USA Today Building (1987-1988

139 e 24% less likely to have ever experienced a miscarriage compared to European women (OR:0.76; CI:0.62

140 ult in a higher rate of completion of missed miscarriage compared with misoprostol alone.

141 nd alcohol use, blacks had increased risk of miscarriage compared with whites (adjusted hazard ratio

142 , 95% CI 0.16, 0.47) decrease in the risk of miscarriage, confirming a strong association between hCG

143 Using a mouse model of recurrent spontaneous miscarriages (DBA/2-mated CBA/J mice) that shares featur

144 ing to conceive 1% of couples have recurrent miscarriages, defined as three or more consecutive pregn

145 rgical removal of fibroids to reduce risk of miscarriage deserves careful scrutiny.

146 oductive performance, including infertility, miscarriage, diabetes-related congenital malformations,

147 2002), we compared 220 pregnancies ending in miscarriage during weeks 12-22 of gestation, with 218 pr

148 nomic DNA from clinical cases of spontaneous miscarriage (EPLs; 14-65 days of gestation) and healthy

149 Our results show that miscarriage etiopathogenesis is partly driven by genetic

150 These serious consequences include miscarriage, fetal death or an infant born with birth de

151 can lead to severe fetal outcomes, including miscarriage, fetal death, preterm birth, intrauterine gr

152 -up studies of these couples showed a higher miscarriage/fetal-anomaly rate of 5/10 (50%) compared to

153 c villi was assessed in chromosomally normal miscarriages from women with RM (N = 33) or isolated mis

154 arriage traditionally use gestational age at miscarriage (GAM) to assign time in survival analyses, w

155 omen with a history of unexplained recurrent miscarriage (>/=2 consecutive miscarriages before 15 wee

156 with women with no miscarriages, women with miscarriages had 1.13 (1.03-1.24), 1.16 (1.07-1.25), and

157 ng early pregnancy, and women with recurrent miscarriage have lower endometrial expression of FST dur

158 higher MF levels had 2.72 times the risk of miscarriage (hazard ratio = 2.72, 95% CI: 1.42-5.19) tha

159 ons between specific food groups and risk of miscarriage; however, to our knowledge, no previous stud

160 ted with a >2-fold increased adjusted HR for miscarriage (HR: 2.50; 95% CI: 1.10, 5.69).

161 s disease who experienced a second-trimester miscarriage in association with documented placental SAR

162 No difference was noted in miscarriage in first-line falciparum treatments with art

163 are causative of congenital malformation and miscarriage in humans and mice.

164 ociations between PFAS exposures and risk of miscarriage in humans are not well studied.

165 ic prophylaxis in the surgical management of miscarriage in low-income countries.

166 ic prophylaxis in the surgical management of miscarriage in Malawi, Pakistan, Tanzania, and Uganda.

167 Presence of fibroids was associated with miscarriage in models without adjustments.

168 10(-8), odds ratio (OR) = 1.4) for sporadic miscarriage in our European ancestry meta-analysis and t

169 was conducted to identify studies reporting miscarriage in women with and without history of exposur

170 plementation trial was done to assess ORs of miscarriage in women with low alpha-tocopherol (<12.0 mu

171 overy at birth, symptomatic hypotension, and miscarriage in women.

172 h pandemic influenza causing first trimester miscarriages in approximately 1 in 10 pregnant women.

173 were attributable to excess first trimester miscarriages in approximately 1 in 10 women who were pre

174 t contribute to the high rate of spontaneous miscarriages in human pregnancies.

175 iovascular disease, and an increased risk of miscarriages in humans.

176 disruption may contribute to thrombosis and miscarriages in the antiphospholipid syndrome (APS).

177 men, 1 gave birth to a healthy infant, 2 had miscarriages in the first trimester, and 1 had fetal dea

178 by recurrent arterial/venous thrombosis and miscarriages in the persistent presence of autoantibodie

179 een PER2 transcript levels and the number of miscarriages in women suffering reproductive failure (Sp

180 ications to women with unexplained recurrent miscarriage, in the presence or absence of inherited thr

181 ere analysed for first-trimester malaria and miscarriage, in which 2558 (10%) had first-trimester mal

182 ptions are aneuploid, leading to spontaneous miscarriages, in vitro fertilization failures and, when

183 The hazard of miscarriage increased 1.61-fold after an initial first-t

184 The risk of miscarriage increased with the amount smoked (1% increas

185 ns were dose dependent, with each additional miscarriage increasing the rates of myocardial and cereb

186 analysis by gestational weeks (10 weeks) of miscarriage indicated positive associations of MEP, MEOH

187 ders (fetal growth restriction and recurrent miscarriage), indicating a role early in gestation for t

188 ve RM, more than three months after the last miscarriage, indicating that the memory CD8-T cell popul

189 regularity, age at first birth, stillbirths, miscarriages, infertility >/=1 year, infertility cause,

190 and are often diagnosed because of recurrent miscarriages, infertility, or aneuploid offspring.

191 Miscarriage is a common and poorly understood adverse pr

192 Miscarriage is a common, complex trait affecting ~15% of

193 We demonstrate that unexplained recurrent miscarriage is associated with significantly decreased e

194 Miscarriage is the most common negative outcome of pregn

195 omen with a history of unexplained recurrent miscarriages is uncertain.

196 Spontaneous abortion, or miscarriage, is a complication of pregnancy which can se

197 irths (>/=22 wk), and 137 (35%) terminations/miscarriages (<22 wk).

198 ages from women with RM (N = 33) or isolated miscarriage (M; N = 21) and elective terminations (TA; N

199 prostol to increase the chance of successful miscarriage management, while reducing the need for misc

200 ative Perinatal Project cohort who had had a miscarriage (n=439) and controls (n=373) matched by gest

201 t-to-treat analyses that excluded women with miscarriages (n = 6), gestational diabetes (n = 32), or

202 ngs regularly care for patients experiencing miscarriage, neonatal death and stillbirth as part of th

203 Miscarriage occurred in three (0.2%) participants in the

204 Induced abortions and miscarriages occurred in 16 (8.2%) and 20 (10.3%) patien

205 Miscarriage occurs in 15% of clinical pregnancies.

206 gnancy was associated with decreased odds of miscarriage (odds ratio = 0.43, 95% confidence interval:

207 on, use of another contraceptive, history of miscarriage or abortion for the first pregnancy, or havi

208 opment, and are a major cause of spontaneous miscarriage or birth defects.

209 PORTANCE In utero HCMV infection can lead to miscarriage or childhood disabilities, and an effective

210 hromosome segregation - essential to prevent miscarriage or developmental defects - thus occur throug

211 er a livebirth and at least 6 months after a miscarriage or induced abortion before conceiving again,

212 it is unclear whether a pregnancy ending in miscarriage or induced abortion confers any protection.

213 ive births, and the possibility that data on miscarriage or induced abortion could have influenced th

214 yroid peroxidase antibodies and a history of miscarriage or infertility.

215 nate, dihydroartemisinin, or artemether) and miscarriage or malformation was assessed using Cox regre

216 We noted no evidence of an increased risk of miscarriage or of major congenital malformations associa

217 lammatory mediators, which in turn may cause miscarriage or premature birth.

218 er PFOA nor PFOS showed any association with miscarriage or preterm birth.

219 our analysis was pregnancy loss (spontaneous miscarriage or stillbirth), and the secondary endpoints

220 was not associated with an increased risk of miscarriage or stillbirth.

221 pregnancies in the United States may end in miscarriage or stillbirth.

222 their outcome (live birth, perinatal death, miscarriage or termination) among women aged 15-45 years

223 in primigravidae or in women with a previous miscarriage or termination.

224 449 women with at least 2 consecutive early miscarriages or 1 late miscarriage were included during

225 egnancies) had increased odds of spontaneous miscarriage (OR 1.54, 95% CI 1.02-2.32; I(2)=67%), antep

226 significant, after controlling for previous miscarriage (OR = 3.3, 95% CI = 1.4-7.8, P = 0.006).

227 l for gestational age, very low birthweight, miscarriage, or neonatal death, although few data were a

228 tational age, birthweight, pregnancy loss or miscarriage, or pre-eclampsia.

229 ing ectopic pregnancy (EP) versus livebirth, miscarriage, or termination in a first pregnancy.

230 in rates of second pregnancy, livebirth, EP, miscarriage, or terminations and complications of a seco

231 methylation may cause karyotypically normal miscarriage, particularly among women experiencing recur

232 h depression or anxiety have higher risks of miscarriage, perinatal death and decisions to terminate

233 showing increased percent of methylation in miscarriage placentas.

234 l outcomes including preterm delivery, early miscarriage, postpartum endometritis, and low birth weig

235 with pregnancy complications, including late miscarriage, preeclampsia, and fetal growth restriction.

236 Does ancestry also influence the risk of miscarriage (pregnancy loss <20 weeks) in high-altitude

237 e association between self-reported race and miscarriage (pregnancy loss at <20 weeks) in a community

238 opherol were associated with reduced odds of miscarriage (pregnancy losses <24 wk of gestation) in wo

239 ted four adverse fetal outcomes: stillbirth, miscarriage, preterm birth, and low birthweight.

240 istic bacterial pathogen that contributes to miscarriage, preterm birth, and serious neonatal infecti

241 premature rupture of membranes, PTB, or late miscarriage; previous short cervix or short cervix this

242 or myelofibrosis and 5% had thrombosis; the miscarriage rate in thrombocythemic patients was 14%.

243 ther AH significantly changes live birth and miscarriage rates needs further investigations.

244 between arrest of pregnancy development and miscarriage represents a window in which the pregnancy i

245 correctly estimate the amniocentesis-related miscarriage risk (73.8% vs 59.0%; OR, 1.95 [95% CI, 1.39

246 e used proportional hazard models to examine miscarriage risk among black women compared with white w

247 accurate and consistent characterization of miscarriage risk associated with time-varying exposures.

248 the authors, or might represent an increased miscarriage risk only within the subset of the populatio

249 lly defined as during the pregnancy in which miscarriage risk was measured (summary relative risk rat

250 between any of the evaluated chemokines and miscarriage risk.

251 for this chemokine as an early indicator of miscarriage risk.

252 the association between high MF exposure and miscarriage risk.

253 Recurrent miscarriage (RM) affects millions of couples globally, a

254 een 25-45 years (n = 45) suffering recurrent miscarriage (RM), recurrent implantation failure (RIF) o

255 ticularly among women experiencing recurrent miscarriage (RM).

256 ent implantation failure (RIF) and recurrent miscarriages (RM).

257 ficant associations for multiple consecutive miscarriage (rs7859844, MAF = 6.4%, P = 1.3 x 10(-8), OR

258 Women with missed miscarriage should be offered mifepristone pretreatment

259 with impaired fecundity (ectopic pregnancy, miscarriage, stillbirth).

260 observational studies comparing the risk of miscarriage, stillbirth, and major congenital anomaly (p

261 ational age, very small for gestational age, miscarriage, stillbirth, and neonatal death.

262 The corresponding risks of miscarriage, stillbirth, and pregnancy loss in a sensiti

263 The rates of miscarriage, stillbirth, pregnancy loss, and congenital

264 associated with adverse pregnancy outcomes (miscarriage, stillbirth, preterm, small-for-gestational

265 d 2008, we identified a cohort of women with miscarriages, stillbirths, or live singleton births.

266 ociation between 25(OH)D and first-trimester miscarriages, suggesting vitamin D as a modifiable risk

267 fertility clinic attendees and in women with miscarriage suggests a potential role for C trachomatis

268 moking was associated with increased risk of miscarriage (summary relative risk ratio = 1.23, 95% con

269 Antibiotic prophylaxis before miscarriage surgery did not result in a significantly lo

270 be confident that antibiotic prophylaxis in miscarriage surgery is cost-effective.

271 prophylaxis, if implemented routinely before miscarriage surgery, could translate to an annual total

272 iage management, while reducing the need for miscarriage surgery.

273 phylaxis for reducing pelvic infection after miscarriage surgery.

274 en reporting the combined adverse outcome of miscarriage, termination of pregnancy, stillbirth, or ne

275 ignificantly higher ratios of live-births to miscarriages than women of Mestizo or European ancestry

276 at translocation defects could contribute to miscarriages that are caused by polyspermy.

277 For miscarriage, the OR was 3.51 (95% CI 1.15-10.77, I(2)=0.

278 Our data suggest that NMO-IgG can cause miscarriage, thus challenging the concept that NMO affec

279 Prior evidence attributing miscarriage to fibroids is potentially biased.

280 ere is little physiological evidence linking miscarriage to stress.

281 We randomly assigned women with recurrent miscarriages to receive twice-daily vaginal suppositorie

282 However, epidemiologic studies of miscarriage traditionally use gestational age at miscarr

283 onal age at arrest of development (GAAD) and miscarriage using transvaginal ultrasound in 500 women r

284 quired surgical intervention to complete the miscarriage versus 87 (25%) of 353 women in the placebo

285 The median gap between GAAD and miscarriage was 23 days (interquartile range, 15-32).

286 Miscarriage was defined as loss before 20 weeks' gestati

287 The adjusted hazard of first-trimester miscarriage was lower with higher 25(OH)D concentrations

288 History of miscarriage was not associated with preeclampsia risk.

289 The risk of miscarriage was significantly higher in women with a his

290 The contribution of the terminal complex to miscarriage was supported by the finding that pregnancy

291 census of abortion providers; the number of miscarriages was estimated using data from the National

292 n induced abortions, although information on miscarriages was of lower quality.

293 t 2 consecutive early miscarriages or 1 late miscarriage were included during 5 to 8 weeks' gestation

294 iation between active or passive smoking and miscarriage were included in the meta-analysis.

295 pregnant women and newborns and one related miscarriage were reported.

296 of couples with increased risk of subsequent miscarriage who would benefit from a personalized interv

297 ther investigate the genetic architecture of miscarriage with biobank-scale Mendelian randomization,

298 In comparison with women with an initial miscarriage, women who had an EP had a lower chance of a

299 Compared with women with no miscarriages, women with miscarriages had 1.13 (1.03-1.2

300 er (aneuploidy) is a common finding in human miscarriage, yet is rarely reported in domestic animals.